Cannabinoids, the principal psychoactive constituents of marijuana, have profound effects on mood, memory, movement, and nocioception. Acting via the neuronal cannabinoid receptor (CB1), these compounds are potent modulators of ion channel function. Specifically, they inhibit N- and Q- type voltage-dependent calcium channels and activate inwardly-rectifying potassium channels. These actions suggest that cannabinoids may elicit their behavioral effects by decreasing neuronal excitability and neurotransmitter release from CB1- expressing neurons. During the next five years we propose to study in detail the molecular events involved in cannabinoids inhibition of neurotransmitter release and neuronal excitability, the modulation of these responses by protein kinase C, and the early molecular events associated with the development of tolerance to cannabinoids. These studies involve three major aims: 1. Defining the extent and mechanisms of inhibition of neurotransmitter release by cannabinoids in neuronal cultures using electrophysiological and imaging techniques. 2. Delineating the role of protein kinase C (PKC) in cannabinoid signaling. Recently we have found that ion channel modulation by cannabinoids is strongly disrupted by protein kinase C activation and that CB1 receptor is a substrate for PKC. We will determine if CB1 phosphorylation occurs in situ, if nurotransmitter activation of PKC disrupts CB1 signaling, and if PKC activation prevents cannabinoid-mediated inhibition of neurotransmitter release. 3. Identifying the molecular events associated with the development of cannabinoid tolerance. These studies will significantly advance our understanding of the cellular actions of cannabinoids. There are three reasons why this is imnportant: (1) Interest in marijuana is increasing and is a significant social issue (witness the ballot initatives in a number of states); (2) cannabinoids have therapeutic potential and we need a firm appreciation of their cellular physiology to exploit this potential; (3) we know little about the physiological role of endogenous cannabinoids in health or diseased brain.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA011322-02
Application #
2882631
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Pollock, Jonathan D
Project Start
1998-04-01
Project End
2003-02-28
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Washington
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Mitjavila, Jose; Yin, Danielle; Kulkarni, Pushkar M et al. (2018) Enantiomer-specific positive allosteric modulation of CB1 signaling in autaptic hippocampal neurons. Pharmacol Res 129:475-481
Sepers, Marja D; Smith-Dijak, Amy; LeDue, Jeff et al. (2018) Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model. J Neurosci 38:544-554
Chen, Yi-Hung; Lee, Hsin-Jung; Lee, Ming Tatt et al. (2018) Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray. Proc Natl Acad Sci U S A 115:E10720-E10729
Zhong, Haixing; Tong, Li; Gu, Ning et al. (2017) Endocannabinoid signaling in hypothalamic circuits regulates arousal from general anesthesia in mice. J Clin Invest 127:2295-2309
Ruehle, Sabine; Wager-Miller, James; Straiker, Alex et al. (2017) Discovery and characterization of two novel CB1 receptor splice variants with modified N-termini in mouse. J Neurochem 142:521-533
Wang, Y; Gu, N; Duan, T et al. (2017) Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses. Mol Psychiatry 22:215-226
Dhopeshwarkar, Amey; Murataeva, Natalia; Makriyannis, Alex et al. (2017) Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 Antagonists. J Pharmacol Exp Ther 360:300-311
Xu, Changqing; Hermes, Douglas J; Nwanguma, Blessing et al. (2017) Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein. Mol Cell Neurosci 83:92-102
Marcus, David J; Henderson-Redmond, Angela N; Gonek, Maciej et al. (2017) Mice expressing a ""hyper-sensitive"" form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption. PLoS One 12:e0174826
Lee, Hsin-Jung; Chang, Lu-Yang; Ho, Yu-Cheng et al. (2016) Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray. Neuropharmacology 105:577-586

Showing the most recent 10 out of 213 publications